Stephen Ma - Oct 8, 2025 Form 4 Insider Report for Scilex Holding Co (SCLX)

Role
CFO and COO, Director
Signature
/s/ Stephen Ma
Stock symbol
SCLX
Transactions as of
Oct 8, 2025
Transactions value $
$0
Form type
4
Date filed
10/9/2025, 08:45 AM
Previous filing
Sep 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ma Stephen Hoi CFO and COO, Director C/O SCILEX HOLDING COMPANY, 960 SAN ANTONIO ROAD, PALO ALTO /s/ Stephen Ma 2025-10-09 0001954364

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCLX Incentive Stock Option (right to buy) Award $0 +60K $0.00 60K Oct 8, 2025 Common Stock 60K $17.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares subject to the option shall vest on a monthly basis following the grant date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Notwithstanding the preceding sentence, the shares of Common Stock subject to the Option will not be exercisable until such date as the Issuer's outstanding indebtedness under the Senior Secured Promissory Note issued by the Issuer to Oramed Pharmaceuticals, Inc. on September 21, 2023 and the Tranche B Senior Secured Convertible Notes issued by the Issuer to each of Oramed Pharmaceuticals, Inc., Nomis Bay Ltd., 3i LP and BPY Limited, has been repaid in full.